Serum metabolite signature panel may serve as a potential biomarker for the early clinical diagnosis of RA

According to a study published in Frontiers in Immunology, a serum-based biomarker panel comprising glyceric acid, lactic acid, and 3-hydroxysovaleric acid has the potential to aid in the early diagnosis of rheumatoid arthritis (ERA).   The observational case-control study conducted by Dr. Rodríguez-Muguruza and colleagues performed untargeted metabolomic profiling of serum obtained from 32 patients with ERA and … Read more

The combination of tofacitinib and iguratimod may be effective in refractory RA and secondary OP

According to a recent article published in the International Immunopharmacology, the combined application of tofacitinib and iguratimod may have a greater therapeutic effect on refractory rheumatoid arthritis (RRA) and its associated osteoporotic bone remodeling. In the rat model of collagen-induced arthritis (CIA) + tumor necrosis factor (TNF), the use of tofacitinib and iguratimod showed significant … Read more

Practice of yoga can boost immune regulation and decrease the severity in RA

Rheumatoid Arthritis (RA) is caused by an imbalance of Th17/Treg cells due to a pro-inflammatory environment. T cells in RA show signs of aging and DNA damage, increasing the risk of mutations. According to a recent study published in Scientific Reports, yoga can reduce disease activity, balance Th17/Treg cells, and optimize cytokine levels while altering … Read more

Oral Hydroxychloroquine is safe and effective in treating primary Sjögren’s syndrome-related dry eye disease

Patients with primary Sjögren’s syndrome (pSS) often experience dry eye disease. Hydroxychloroquine (HCQ) has become a significant treatment option for pSS due to its immunomodulatory effects and minimal adverse effects. A recent study published in Alternative Therapies in Health and Medicine demonstrated the effectiveness and safety of HCQ in pSS patients with moderate to severe … Read more

Neutrophil cytosolic factor 4 may serve as a potential biomarker for ankylosing spondylitis

In recent years, biomarkers have gained prominence in the pursuit of early diagnosis for ankylosing spondylitis (AS) and in the selection of appropriate treatment for patients. A recent article published in the Journal of Musculoskeletal and Neuronal Interactions suggests that Neutrophil Cytosolic Factor 4 (NCF4) could serve as a diagnostic and prognostic biomarker for AS.  … Read more

Chitinase-3 like-protein-1 may serve as a potential biomarker in RA patients with interstitial lung disease

Interstitial lung disease (ILD) is a common complication of rheumatoid arthritis (RA), which can lead to serious health problems and even death. A recent article published in Frontiers in Immunology reported increased levels of chitinase-3 like-protein-1 (CHI3L1) in patients with RA-ILD and suggested its promising role as a biomarker.  The study conducted at the Department … Read more